| 3577- | CUR, | Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study |
| - | Trial, | AD, | NA |
| 6238- | CUSP9, | A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3 |
| - | Trial, | GBM, | NA |
| 6241- | CUSP9, | RECURRENT GLIOBLASTOMA: INITIAL EXPERIENCES WITH COMPASSIONATE-USE CUSP9v3/v4 |
| - | Trial, | GBM, | NA |
| 6262- | Cyste, | A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis: Effectiveness on White Blood Cell Cystine Levels and Comparison of Safety |
| - | Trial, | Nor, | NA |
| 6260- | Cyste, | A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers |
| - | Trial, | Nor, | NA |
| 6592- | DAS, | Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial |
| - | Trial, | CML, | NA |
| 6679- | DCA, | GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial |
| - | Trial, | Melanoma, | NA |
| - | Trial, | HNSCC, | NA |
| - | Trial, | BC, | NA |
| - | Trial, | BC, | NA |
| - | Trial, | BC, | NA |
| 6752- | DHA, | A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease |
| - | Trial, | BC, | NA |
| 6754- | DHA, | Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial |
| - | Trial, | AD, | NA |
| 6755- | DHA, | Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia |
| - | Trial, | AD, | NA |
| 6758- | DHA, | Chemo, | Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial |
| - | Trial, | BC, | NA |
| 6760- | DHA, | Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans |
| - | Trial, | Nor, | NA |
| 6761- | DHA, | Docosahexaenoic acid reduces resting blood pressure but increases muscle sympathetic outflow compared with eicosapentaenoic acid in healthy men and women |
| - | Trial, | Nor, | NA |
| 6711- | dietF, | Gut-microbiota-targeted diets modulate human immune status |
| - | Trial, | Nor, | NA |
| 1848- | dietFMD, | Chemo, | Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial |
| - | Trial, | BC, | NA |
| - | Trial, | NA, | NA |
| 1862- | dietFMD, | Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial |
| - | Trial, | Var, | NA |
| 1842- | dietFMD, | Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment |
| - | Trial, | Var, | NA |
| 1841- | dietFMD, | Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer |
| - | Trial, | Var, | NA |
| 5193- | dietMet, | Rad, | A Phase I Trial of a Methionine Restricted Diet with Concurrent Radiation Therapy |
| - | Trial, | Var, | NA |
| 2165- | dietP, | SFN, | Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects—results from the POUDER pilot study |
| - | Trial, | PC, | NA |
| 2160- | dietP, | Dietary proteins and protein sources and risk of death: the Kuopio Ischaemic Heart Disease Risk Factor Study |
| - | Trial, | Heart, | NA |
| - | Trial, | Colon, | NA |
| 6729- | Dipy, | Dipyridamole prevents triple-negative breast-cancer progression |
| - | Trial, | BC, | MDA-MB-231 |
| 6737- | Dipy, | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD) |
| - | Trial, | Nor, | NA |
| 6265- | DL, | Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee |
| - | Trial, | Var, | NA |
| 6266- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer |
| - | Trial, | BC, | NA |
| 6279- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer |
| - | Trial, | BC, | NA |
| 4917- | DSF, | Chemo, | Cu, | Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma |
| - | Trial, | GBM, | NA |
| 6803- | EA, | Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial |
| - | Trial, | IBD, | NA |
| 6612- | Ech, | Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Nor, | NA |
| 6603- | Ech, | doxoR, | The effect of Echinacea purpurea on the pharmacokinetics of docetaxel |
| - | Trial, | Var, | NA |
| 7225- | EGb 761, | Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial |
| - | Trial, | AD, | NA |
| 7232- | EGb 761, | Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial |
| - | Trial, | AD, | NA |
| - | Trial, | Nor, | NA |
| - | Trial, | NA, | NA |
| 653- | EGCG, | Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL) |
| - | Trial, | CLL, | NA |
| 6790- | EPA, | Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia |
| - | Trial, | Lung, | NA |
| 6792- | EPA, | Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico |
| - | Trial, | HNSCC, | NA |
| 5063- | Ex, | A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort |
| - | Trial, | BC, | NA |
| 4137- | Ex, | The impact of exercise on patients with dementia |
| - | Trial, | AD, | NA |
| 5234- | Ex, | Intense Walking Exercise Affects Serum IGF-1 and IGFBP3 |
| - | Trial, | Nor, | NA |
| 5235- | Ex, | Effect of Low-Intensity Aerobic Exercise on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Proteins in Healthy Men |
| - | Trial, | Nor, | NA |
| 5230- | Ex, | Effects of an acute maximal exercise bout on serum insulin-like growth factor-1 in adults with MDD |
| - | Trial, | Nor, | NA |
| 6870- | FA, | Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6884- | FA, | Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid